About Avidity Biosciences
Avidity Biosciences is a company based in San Diego (United States) founded in 2012 was acquired by Novartis in October 2025.. Avidity Biosciences has raised $142.54 million across 7 funding rounds from investors including Lilly, Novartis and ARE. The company has 391 employees as of December 31, 2024. Avidity Biosciences offers products and services including AOC Platform and Pipeline for DM1. Avidity Biosciences operates in a competitive market with competitors including Jazz Pharmaceuticals, GSK, C4 Therapeutics, Erasca and MiRagen, among others.
- Headquarter San Diego, United States
- Employees 391 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Avidity Biosciences, Inc.
-
Annual Revenue
$10.9 M13.99as on Dec 31, 2024
-
Net Profit
$-322.3 M-51.87as on Dec 31, 2024
-
EBITDA
$-376.16 M-61.1as on Dec 31, 2024
-
Total Equity Funding
$142.54 M (USD)
in 7 rounds
-
Latest Funding Round
$400.21 M (USD), Post-IPO
Mar 04, 2024
-
Investors
Lilly
& 18 more
-
Employee Count
391
as on Dec 31, 2024
-
Acquired by
Novartis
(Oct 27, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Avidity Biosciences
Avidity Biosciences is a publicly listed company on the NASDAQ with ticker symbol RNA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Avidity Biosciences
Avidity Biosciences offers a comprehensive portfolio of products and services, including AOC Platform and Pipeline for DM1. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform combines antibodies and oligonucleotides for targeted disease treatment.
Develops treatments for myotonic dystrophy type 1 and related conditions.
Unlock access to complete
Unlock access to complete
Leadership Team
56 people
Software Development Team
32 people
Senior Team
19 people
Operations Team
14 people
Associate Team
14 people
Product Management Team
13 people
Principal Team
11 people
Data Analysis and Operations Team
10 people
Unlock access to complete
Funding Insights of Avidity Biosciences
Avidity Biosciences has successfully raised a total of $142.54M across 7 strategic funding rounds. The most recent funding activity was a Post-IPO round of $400.21 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Post-IPO — $400.2M
-
First Round
First Round
(14 Feb 2014)
- Investors Count 18
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2024 | Amount | Post-IPO - Avidity Biosciences | Valuation |
investors |
|
| Nov, 2019 | Amount | Series C - Avidity Biosciences | Valuation | RTW Investments | |
| Apr, 2019 | Amount | Series B - Avidity Biosciences | Valuation | Lilly |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Avidity Biosciences
Avidity Biosciences has secured backing from 19 investors, including venture fund and institutional investors. Prominent investors backing the company include Lilly, Novartis and ARE. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life Sciences focused VC firm investing in the US
|
Founded Year | Domain | Location | |
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Private equity fund focused on the biotechnology sector
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Avidity Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Avidity Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Avidity Biosciences Comparisons
Competitors of Avidity Biosciences
Avidity Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, GSK, C4 Therapeutics, Erasca and MiRagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Avidity Biosciences
Frequently Asked Questions about Avidity Biosciences
When was Avidity Biosciences founded?
Avidity Biosciences was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Where is Avidity Biosciences located?
Avidity Biosciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Avidity Biosciences?
Sarah Boyce is the current CEO of Avidity Biosciences.
Is Avidity Biosciences a funded company?
Avidity Biosciences is a funded company, having raised a total of $142.54M across 7 funding rounds to date. The company's 1st funding round was a Series B of $15M, raised on Feb 14, 2014.
How many employees does Avidity Biosciences have?
As of Dec 31, 2024, the latest employee count at Avidity Biosciences is 391.
What is the annual revenue of Avidity Biosciences?
Annual revenue of Avidity Biosciences is $10.9M as on Dec 31, 2024.
What does Avidity Biosciences do?
Avidity Biosciences was founded in 2012 in San Diego, United States, within the biotechnology sector focused on oncology. Antibody-siRNA complexes, known as ARCs, are advanced to combine elements of antibody-drug conjugates and nucleic acid therapeutics. Targeted polymeric nanoparticles encapsulating siRNA payloads are created for delivery to specific tumor types. These nanoparticles are decorated with antibodies, proteins, peptides, or small molecules to enable binding to extracellular receptors and promote cellular uptake.
Who are the top competitors of Avidity Biosciences?
Avidity Biosciences's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does Avidity Biosciences offer?
Avidity Biosciences offers AOC Platform and Pipeline for DM1.
Is Avidity Biosciences publicly traded?
Yes, Avidity Biosciences is publicly traded on NASDAQ under the ticker symbol RNA.
Who are Avidity Biosciences's investors?
Avidity Biosciences has 19 investors. Key investors include Lilly, Novartis, ARE, TPG, and RTW Investments.
What is Avidity Biosciences's ticker symbol?
The ticker symbol of Avidity Biosciences is RNA on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.